Search - tctmd.com

Displaying 281 - 300 of 1424

Sort: Relevancy | Date

Presentation TVT 2021

Portico FlexNav Updates

Presenter: Gregory Fontana

July 21, 2021

Presentation TVT 2021

Accurate Neo 2 Updates

Presenter: Lars Sondergaard

July 21, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

Presentation TVT 2021

Postprocedural Management of New LBBB and Other Conduction Disturbances After TAVR

Presenter: Lars Sondergaard

July 21, 2021

Presentation TVT 2021

Too High Can Also Be a Problem

Presenter: Gilbert Tang

July 21, 2021

Presentation TVT 2021

Higher Is Always Better

Presenter: Hemal Gada

July 21, 2021

Presentation TVT 2021

The Changing Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Presenter: Tamim Nazif

July 21, 2021

Presentation TVT 2021

Management of Failed TAVR Bioprostheses: TAV-in-TAV and Surgical TAVR Explanation

Presenter: Tsuyoshi Kaneko

July 20, 2021

Presentation TVT 2021

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

Presenter: Raj Makkar

July 20, 2021

Presentation TVT 2021

Summarizing the New VARC 3 Consensus Definitions of Hemodynamic Valve Deterioration and Bioprosthetic Valve Failure

Presenter: Rebecca Hahn

July 20, 2021

Presentation TVT 2021

Case Presentation: Iliac Dissections During Transfemoral Access/Closure: The Repair Toolbox

Presenter: Curtiss Stinis

July 20, 2021

Presentation TVT 2021

Case Presentation: Moderate-Severe PVL After TAVR: What Now?

Presenter: Anita Asgar

July 20, 2021

Presentation TVT 2021

Case Resolution: The Valve Has Left the Annulus: Embolization Misadventures

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Presentation: The Valve Has Left the Annulus: Embolization Misadventures

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Resolution: Coronary Occlusion During TAVR: The Bad and the Ugly

Presenter: Azeem Latib

July 20, 2021

Presentation TVT 2021

Case Presentation: Coronary Occlusion During TAVR: The Bad and the Ugly

Presenter: Azeem Latib

July 20, 2021

Presentation TVT 2021

What Are We Measuring in TAVR PPM and Does It Impact Clinical Outcomes: Making Sense of the Data

Presenter: Philippe Pibarot

July 20, 2021

Presentation TVT 2021

Comparative Analyses of PPM With SAVR and TAVR

Presenter: Neal Kleiman

July 20, 2021

Advertisement

Portico FlexNav Updates

Accurate Neo 2 Updates

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Postprocedural Management of New LBBB and Other Conduction Disturbances After TAVR

Too High Can Also Be a Problem

Higher Is Always Better

The Changing Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Management of Failed TAVR Bioprostheses: TAV-in-TAV and Surgical TAVR Explanation

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

Summarizing the New VARC 3 Consensus Definitions of Hemodynamic Valve Deterioration and Bioprosthetic Valve Failure

Case Presentation: Iliac Dissections During Transfemoral Access/Closure: The Repair Toolbox

Case Presentation: Moderate-Severe PVL After TAVR: What Now?

Case Resolution: The Valve Has Left the Annulus: Embolization Misadventures

Case Presentation: The Valve Has Left the Annulus: Embolization Misadventures

Case Resolution: Coronary Occlusion During TAVR: The Bad and the Ugly

Case Presentation: Coronary Occlusion During TAVR: The Bad and the Ugly

What Are We Measuring in TAVR PPM and Does It Impact Clinical Outcomes: Making Sense of the Data

Comparative Analyses of PPM With SAVR and TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content